To remove the lesser prairie-chicken from the lists of threatened species and endangered species published pursuant to the Endangered Species Act of 1973 and to amend that Act to exclude the lesser prairie-chicken from the authority of that Act.

FACE Act Repeal Act of 2025

RIFLE Act of 2025 Reining In Federal Licensing Enforcement Act of 2025

Ending Chemical Abortions Act of 2025

Accountability for Lawless Violence In our Neighborhoods Act or the ALVIN ActThis bill prohibits federal funds from being awarded or otherwise made available to the Manhattan District Attorney’s Office in New York. The bill also (1) rescinds any unobligated funds that were allocated for or otherwise made available to the office, and (2) directs the Department of Justice to require the office to reimburse the federal government for all funds that were expended for the office after January 1, 2022.

Federal Insurance Office Elimination Act

National Constitutional Carry Act

Federal Employee Student Debt Transparency ActThis bill requires certain executive branch employees to disclose their federal student loan debt in an annual report.The bill's requirement applies to an employee serving in a Senior Executive Service position or a position of a confidential or policy-determining nature (i.e., a Schedule C position). Covered employees must file a report detailing the principal and interest owed on loans under the William D. Ford Federal Direct Loan Program, the Federal Family Education Loan Program, and the Federal Perkins Loan Program. The bill also requires the Office of Government Ethics to submit an annual report to Congress that contains (1) the total amount owed by all covered employees, and (2) the name of any covered employee who failed to report the required information. 

Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

MERIT Act of 2025 Modern Employment Reform, Improvement, and Transformation Act of 2025